Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016;3:34. https://doi.org/10.1186/s40662-016-0063-5.

Article  PubMed  Google Scholar 

Wong WL, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16. https://doi.org/10.1016/s2214-109x(13)70145-1.

Article  PubMed  Google Scholar 

Teo ZL, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–91. https://doi.org/10.1016/j.ophtha.2021.04.027.

Article  PubMed  Google Scholar 

Fahim AT, Daiger SP, Weleber RG. Nonsyndromic retinitis pigmentosa overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®). Seattle (WA): University of Washington, Seattle. Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved. 1993.

Rein DB, et al. Prevalence of age-related macular degeneration in the US in 2019. JAMA Ophthalmol. 2022;140(12):1202–8. https://doi.org/10.1001/jamaophthalmol.2022.4401.

Article  PubMed  PubMed Central  Google Scholar 

Schmidt-Erfurth U, et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014;121(1):193–201. https://doi.org/10.1016/j.ophtha.2013.08.011.

Article  PubMed  Google Scholar 

Campochiaro PA, et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther. 2006;17(2):167–76. https://doi.org/10.1089/hum.2006.17.167.

Article  CAS  PubMed  Google Scholar 

Russell S, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390(10097):849–60. https://doi.org/10.1016/s0140-6736(17)31868-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu CL, Park KS, Tsang SH. CRISPR/Cas9 genome surgery for retinal diseases. Drug Discov Today Technol. 2018;28:23–32. https://doi.org/10.1016/j.ddtec.2018.05.001.

Article  PubMed  PubMed Central  Google Scholar 

Pierce EA, Bennett J. The status of RPE65 gene therapy trials: safety and efficacy. Cold Spring Harb Perspect Med. 2015;5(9):a017285. https://doi.org/10.1101/cshperspect.a017285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng C, et al. Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis. Graefes Arch Clin Exp Ophthalmol. 2022;260(5):1543–50. https://doi.org/10.1007/s00417-021-05508-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gardiner KL, et al. Long-term structural outcomes of late-stage RPE65 gene therapy. Mol Ther. 2020;28(1):266–78. https://doi.org/10.1016/j.ymthe.2019.08.013.

Article  CAS  PubMed  Google Scholar 

ROCKVILLE, REGENXBIO announces additional positive long-term and interim phase I/IIa trial update for RGX-314 for the treatment of wet AMD, ed, 2020.

Campochiaro PA, et al. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study. Lancet. 2024;403(10436):1563–73. https://doi.org/10.1016/s0140-6736(24)00310-6.

Article  CAS  PubMed  Google Scholar 

Saundankar V, et al. Annual prevalence of geographic atrophy and wet age-related macular degeneration among Medicare Advantage enrollees in a US health plan. J Manag Care Spec Pharm. 2025;31(1):88–94. https://doi.org/10.18553/jmcp.2025.31.1.88.

Article  PubMed  PubMed Central  Google Scholar 

Macular degeneration facts & figures, ed, 2024.

Chung H, Kim C. Nutlin-3a for age-related macular degeneration. Aging (Albany NY). 2022;14(14):5614–6. https://doi.org/10.18632/aging.204187.

Article  PubMed  Google Scholar 

Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A. Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet. 2014;15:151–71. https://doi.org/10.1146/annurev-genom-090413-025610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merle BMJ, et al. Mediterranean diet and incidence of advanced age-related macular degeneration: the EYE-RISK Consortium. Ophthalmology. 2019;126(3):381–90. https://doi.org/10.1016/j.ophtha.2018.08.006.

Article  PubMed  Google Scholar 

Kaarniranta K, et al. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res. 2020;79:100858. https://doi.org/10.1016/j.preteyeres.2020.100858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khanani AM, et al. Review of gene therapies for age-related macular degeneration. Eye (Lond). 2022;36(2):303–11. https://doi.org/10.1038/s41433-021-01842-1.

Article  PubMed  Google Scholar 

Bellingrath JS, Li KV, Aziz K, Izzi JM, Liu YV, Singh MS. Large animal model species in pluripotent stem cell therapy research and development for retinal diseases: a systematic review. Front Ophthalmol (Lausanne). 2024;4:1377098. https://doi.org/10.3389/fopht.2024.1377098.

Article  PubMed  Google Scholar 

Busbee B, et al. Phase 1 study of intravitreal gene therapy with ADVM-022 for neovascular AMD (OPTIC trial). Investig Ophthalmol Vis Sci. 2021;62(8):352–352.

Google Scholar 

Steel DH, Donachie PHJ, Aylward GW, Laidlaw DA, Williamson TH, Yorston D. Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (Lond). 2021;35(1):316–25. https://doi.org/10.1038/s41433-020-0844-x.

Article  CAS  PubMed  Google Scholar 

Kuhn F, Aylward B. Rhegmatogenous retinal detachment: a reappraisal of its pathophysiology and treatment. Ophthalmic Res. 2014;51(1):15–31. https://doi.org/10.1159/000355077.

Article  PubMed  Google Scholar 

Fung AT, Galvin J, Tran T. Epiretinal membrane: a review. Clin Exp Ophthalmol. 2021;49(3):289–308. https://doi.org/10.1111/ceo.13914.

Article  PubMed  Google Scholar 

Bond-Taylor M, Jakobsson G, Zetterberg M. Posterior vitreous detachment - prevalence of and risk factors for retinal tears. Clin Ophthalmol. 2017;11:1689–95. https://doi.org/10.2147/opth.S143898.

Article  PubMed  PubMed Central  Google Scholar 

Das A. Diabetic retinopathy: battling the global epidemic. Indian J Ophthalmol. 2016;64(1):2–3. https://doi.org/10.4103/0301-4738.178155.

Article  PubMed  PubMed Central  Google Scholar 

Lundeen EA, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747–54. https://doi.org/10.1001/jamaophthalmol.2023.2289.

Article  PubMed  PubMed Central  Google Scholar 

Zlatarova Z, et al. Prevalence of diabetic retinopathy among diabetic patients from northeastern Bulgaria. Diagnostics (Basel). 2024. https://doi.org/10.3390/diagnostics14202340.

Article  PubMed  PubMed Central  Google Scholar 

Wells JA, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 2016;123(6):1351–9. https://doi.org/10.1016/j.ophtha.2016.02.022.

Article  PubMed  Google Scholar 

Nguyen QD, et al. Brolucizumab: evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration. Ophthalmology. 2020;127(7):963–76. https://doi.org/10.1016/j.ophtha.2019.12.031.

Article  PubMed